Royalty Pharma
Mr. McGivern joined Royalty Pharma in 2022. Previously, Mr. McGivern was a partner in Goodwin Procter’s Life Sciences practice. Mr. McGivern holds a BS in civil engineering from Tufts University and a JD from Boston University.
This person is not in any teams
This person is not in any offices
Royalty Pharma
3 followers
Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals, and not-for-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies.